Yüklüyor......
Is there a role for retinoids to treat minimal residual disease in neuroblastoma?
A variety of pre-clinical and clinical data point toward high drug levels of retinoids being required to achieve optimal efficacy against neuroblastoma. The results of the Kohler trial reported in this issue demonstrate that low-dose 13-cis-RA does not have clinical efficacy against neuroblastoma in...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Nature Publishing Group
2000
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2363592/ https://ncbi.nlm.nih.gov/pubmed/11027422 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2000.1430 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|